We scan new podcasts and send you the top 5 insights daily.
Judi Health disrupted the pharmacy benefits market not with a novel business model, but by reviving an older one from the 80s and 90s. They reverted to a flat administrative fee, directly counter-positioning themselves against incumbents who had evolved to a conflicted, opaque model of profiting from higher drug costs.
Prepared realized it couldn't win against GovTech incumbents on their terms of sales relationships and lobbying. Their strategy was to fundamentally shift the competition. By offering a free, easy-to-use product, they forced the purchasing decision to be about technology quality, an arena where they could excel.
Netflix’s initial disruption wasn't just mailing DVDs. It was shifting the industry from Blockbuster's punitive, transaction-based model (built on late fees) to a consumer-friendly subscription model with no late fees. This fundamental business model innovation was the true competitive advantage even before streaming.
The US healthcare system rewards inefficiency, with multiple parties adding costs. Cash-pay systems bypass this, offering services and drugs at a lower net price by avoiding negotiations and markups inherent in the insurance-based model.
SmithRx CEO Jake Friends argues that new PBM transparency laws fail. The proof is that the stocks of the large, regulated PBMs rose after the legislation passed, as markets understood that profit pools would simply shift and the laws would increase barriers to entry for competitors.
Startup With Coverage's innovation isn't just tech; it's a business model shift. By charging a flat service fee instead of commissions, they align incentives to find clients the best, most affordable insurance, unlike traditional brokers who profit from higher premiums.
Judi Health couldn't match the purchasing power of its giant competitors. Instead of competing on gross cost, they focused on being 70% more operationally efficient. This allowed them to offer a lower *net* cost to customers, proving that startups can win on price by focusing on superior internal operations, not just scale.
Legacy PBMs run on rigid, antiquated systems like COBOL, inhibiting their ability to find dynamic cost-saving pathways. SmithRx's modern, distributed architecture connects to new low-cost options (like Mark Cuban Cost Plus) and leverages AI to lower its own service costs, creating a dual advantage.
Judi Health found its first customers in unions and the public sector. These organizations are ideal early adopters for cost-saving B2B products because, unlike many corporations, they operate on fixed budgets. This makes them highly sensitive to price and sustainability, motivating them to try new, more efficient solutions.
Legacy credit card companies can't simply match Robinhood's 3% offer due to their massive headcounts and marketing spend. Adopting a tech-first, low-cost model would require painful restructuring that cannibalizes their existing, profitable business—a classic innovator's dilemma.
Beyond low-cost generic drugs, Cuban's company negotiates directly with hospitals for better prices. The truly disruptive move is publishing this transparent contract online (at costpluswellness.com), empowering any self-insured business to bypass insurance middlemen and access the same pre-negotiated rates.